www.fdanews.com/articles/190884-ischemaview-nabs-israels-approval-for-stroke-imager
iSchemaView Nabs Israel’s Approval for Stroke Imager
April 9, 2019
Israel’s medical device regulator has approved iSchemaView’s RAPID imaging platform, used for analyzing ischemic stroke.
The platform includes MRI, CT perfusion and CT angiography capabilities, as well as a standardized score generator that lets physicians easily share and discuss a patient’s condition.
The device provides physicians with color-coded maps of the brain and its regions for simpler interpretation of ischemic changes.